Depending on the tumour cell type, the EMT is based on an aerobic glycolytic program and unveils a lipogenic metabolism depending on the EMT inducer (e.g., TNF-α versus TGF-β-derived Snail1). The gene discussed is SNAI1; the disease is neoplasm.